SCHEMBL7244172

SCHEMBL7244172

O=C(C#CCCCCN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 19/20 0.61
ERBB2 P04626 10/20 0.61
ERBB4 Q15303 4/20 0.61
AURKA O14965 2/20 0.55
AURKB Q96GD4 2/20 0.55
BTK Q06187 2/20 0.49
ROCK2 O75116 1/20 0.49
ALDH1A1 P00352 1/20 0.49
LCK P06239 1/20 0.49
FYN P06241 1/20 0.49
RET P07949 1/20 0.49
MET P08581 1/20 0.49
MAPT P10636 1/20 0.49
SRC P12931 1/20 0.49
PDGFRA P16234 1/20 0.49
LTK P29376 1/20 0.49
TTK P33981 1/20 0.49
KDR P35968 1/20 0.49
MAP2K2 P36507 1/20 0.49
MAP2K1 Q02750 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7237483 0.92 EGFR (0.63) EGFRERBB2ERBB4AURKAAURKB
SCHEMBL7237640 0.91 EGFR (0.63) EGFRERBB2ERBB4AURKAAURKB
SCHEMBL7127934 0.90 EGFR (0.70) EGFRERBB2ERBB4AURKAAURKB
SCHEMBL7242049 0.90 EGFR (0.61) EGFRERBB2ERBB4AURKAAURKB
SCHEMBL7241852 0.84 EGFR (0.62) EGFRERBB2AURKAAURKBMAPT
SCHEMBL7216113 0.84 EGFR (0.81) EGFRERBB2ERBB4
SCHEMBL7120344 0.83 EGFR (0.60) EGFRERBB2ERBB4AURKAAURKB
SCHEMBL7236783 0.83 EGFR (0.65) EGFRERBB2ERBB4AURKAAURKB
SCHEMBL7233932 0.82 EGFR (0.61) EGFRERBB2AURKAAURKBBTK
SCHEMBL7245617 0.82 EGFR (0.73) EGFRERBB2ERBB4AURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127374-A AN ENZYME INHIBITOR FOR TREATING CANCER, RESTENOSIS, ATHEROSCLEROSIS, ENDOMETRIOSIS AND PSORIASIS WARNER-LAMBERT COMPANY (US) 2000-10-03 US claimed
US-6562818-B1 For treating cancer, atherosclerosis, restenosis, endometriosis, and psoriasis WARNER-LAMBERT COMPANY 2003-05-13 US disclosed